NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

HyGro,

If you can’t tell me why macrophage infiltration has often been a problem after treatment with L in this trial but is much less of a problem with properly administered L with adjuvants or in combo with certain checkpoint inhibitors or Direct, then your opinion about NWBO as an investment really isn’t capturing the value of the science which is in line with your conclusion. I have been invested long since 2012 and already have significant gains because of cost averaging down during all this time. This is also my only biotech holding and has been for years. If you haven’t figured it out by now, some of us have just been waiting all this time for the formal validation of the science once commercial scale manufacturing for a new SOC in GBM, rGBM and probably lower grade gliomas soon after had a chance to catch up. This platform will reach quickly into label extensions and Direct and or an L/Direct synergistic combo will completely change cancer treatment. Big picture HyGro, you should have been looking at the big picture. Best wishes.